Cargando…
Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses?
David K. Shay and Benjamin Ridenhour discuss a modeling study predicting that stockpiling a secondary antiviral for use early in a flu pandemic can forestall resistance to the primary stockpiled drug.
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694987/ https://www.ncbi.nlm.nih.gov/pubmed/19564898 http://dx.doi.org/10.1371/journal.pmed.1000103 |
| _version_ | 1782168142096629760 |
|---|---|
| author | Shay, David K. Ridenhour, Benjamin J. |
| author_facet | Shay, David K. Ridenhour, Benjamin J. |
| author_sort | Shay, David K. |
| collection | PubMed |
| description | David K. Shay and Benjamin Ridenhour discuss a modeling study predicting that stockpiling a secondary antiviral for use early in a flu pandemic can forestall resistance to the primary stockpiled drug. |
| format | Text |
| id | pubmed-2694987 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-26949872009-06-30 Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses? Shay, David K. Ridenhour, Benjamin J. PLoS Med Perspective David K. Shay and Benjamin Ridenhour discuss a modeling study predicting that stockpiling a secondary antiviral for use early in a flu pandemic can forestall resistance to the primary stockpiled drug. Public Library of Science 2009-06-30 /pmc/articles/PMC2694987/ /pubmed/19564898 http://dx.doi.org/10.1371/journal.pmed.1000103 Text en This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
| spellingShingle | Perspective Shay, David K. Ridenhour, Benjamin J. Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses? |
| title | Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses? |
| title_full | Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses? |
| title_fullStr | Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses? |
| title_full_unstemmed | Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses? |
| title_short | Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses? |
| title_sort | can we “hedge” against the development of antiviral resistance among pandemic influenza viruses? |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694987/ https://www.ncbi.nlm.nih.gov/pubmed/19564898 http://dx.doi.org/10.1371/journal.pmed.1000103 |
| work_keys_str_mv | AT shaydavidk canwehedgeagainstthedevelopmentofantiviralresistanceamongpandemicinfluenzaviruses AT ridenhourbenjaminj canwehedgeagainstthedevelopmentofantiviralresistanceamongpandemicinfluenzaviruses |